Erin Colley, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10098 Bear Creek Rd, Lucasville, OH 45648 Phone: 740-259-5536 Fax: 740-259-4259 |
Sarah Slone, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 213 Judy Ln, Lucasville, OH 45648 Phone: 740-981-8949 |
Jennifer Sommer, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10098a Big Bear Creek Rd, Lucasville, OH 45648 Phone: 740-259-2351 |
Mrs. Janel Lynn Davis, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10098 Big Bear Creek Rd, Lucasville, OH 45648 Phone: 740-259-0938 |
Taylor Gabrielle Shope Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 497 Glendale Rd, Lucasville, OH 45648 Phone: 606-923-2320 |
News Archive
Women may reduce the risk of their breast cancer returning by starting treatment with Femara (letrozole tablets) anywhere from one to seven years after finishing tamoxifen therapy, according to a new analysis published in the Journal of Clinical Oncology.
TransTech Pharma, Inc., announced today that recruitment of patients for its recently initiated, multi-center Phase 2 clinical trial of TTP054 in type 2 diabetics, is exceeding expectations with initial top line results available in early 2013. The 90-day proof of concept study is being conducted in type 2 diabetics not well controlled with approved oral anti-diabetic agents.
Investigators from the Slone Epidemiology Center at Boston University School of Medicine (BUSM) have reported that African American women who consume more vegetables are less likely to develop estrogen receptor-negative breast cancer than women with low vegetable intake. The study results, published in the American Journal of Epidemiology, were based on data from the Black Women's Health Study (BWHS), a large follow-up study of 59,000 African American women from across the U.S. conducted by investigators at the Slone Epidemiology Center since 1995.
Medical oncologists across the nation want to know whether a certain drug combination can slow the progression of male breast cancer, a rare disease that often goes undiagnosed until it's in an advanced stage.
› Verified 5 days ago